Disease severity | All patients (n = 40) | Eradicated group (n = 26) | Not eradicated group (n = 14) | ||||||
---|---|---|---|---|---|---|---|---|---|
 | H. pylori therapy | P value | H. pylori therapy | P value | H. pylori therapy | P value | |||
 | Before | After |  | Before | After |  | Before | After |  |
Persistent symptoms | 40 | 23 | <0.001a | 26 | 12 | <0.001a | 14 | 11 | 0.22a |
Grade of nodular disease | |||||||||
Grade 0 | 0 | 5 | 0.005b | 0 | 5 | 0.002b | 0 | 0 | 0.91b |
Grade 1 | 4 | 12 | Â | 2 | 9 | Â | 2 | 3 | Â |
Grade 2 | 10 | 11 | Â | 7 | 7 | Â | 3 | 3 | Â |
Grade 3 | 20 | 10 | Â | 14 | 4 | Â | 6 | 4 | Â |
Grade 4 | 6 | 2 | Â | 3 | 1 | Â | 3 | 4 | Â |
Mean ± 1SD Score | 2.70 ± 0.84 | 1.83 ± 1.06 | <0.001c | 2.69 ± 0.79 | 1.50 ± 1.10 | <0.001c | 2.71 ± 0.96 | 2.64 ± 1.15 | 0.58c |